TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 104 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $595,875 | +40741.3% | 87,500 | -69.8% | 0.00% | -50.0% |
| Q3 2023 | $1,459 | +213.1% | 290,100 | +445.3% | 0.00% | +100.0% |
| Q2 2023 | $466 | -62.6% | 53,200 | -49.4% | 0.00% | -50.0% |
| Q1 2023 | $1,246 | +6.5% | 105,200 | -8.4% | 0.00% | 0.0% |
| Q4 2022 | $1,170 | -99.9% | 114,900 | -24.5% | 0.00% | +100.0% |
| Q3 2022 | $896,000 | +96.1% | 152,200 | -17.5% | 0.00% | 0.0% |
| Q2 2022 | $457,000 | +127.4% | 184,416 | +172.0% | 0.00% | – |
| Q1 2022 | $201,000 | – | 67,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 714,285 | $2,121,000 | 0.65% |
| Vivo Capital, LLC | 2,675,133 | $7,945,000 | 0.55% |
| Samsara BioCapital, LLC | 289,068 | $859,000 | 0.22% |
| Orbimed Advisors | 3,791,204 | $11,260,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,345,959 | $6,967,000 | 0.16% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,238,800 | $3,679,000 | 0.11% |
| Antara Capital LP | 1,074,834 | $3,192,000 | 0.10% |
| COWEN AND COMPANY, LLC | 85,000 | $252,000 | 0.02% |
| Marquette Asset Management, LLC | 21,802 | $65,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 85,851 | $255,000 | 0.01% |